δ-Opioid Receptors Expressed by Jurkat T Cells Enhance IL-2 Secretion by Increasing AP-1 Complexes and Activity of the NF-AT/AP-1-Binding Promoter Element

Karen Elaine Hedin, Michael P. Bell, Kimberly R. Kalli, Catherine J. Huntoon, Burt M. Sharp, David J. McKean

Research output: Contribution to journalArticle

59 Scopus citations

Abstract

Recent molecular evidence points to transient and/or stage-specific expression of δ- and κ-opioid receptors by thymic and peripheral T lymphocytes. Since medical treatments or stress commonly increase opioid levels, it is important to understand the mechanisms by which opioids affect T lymphocyte functions. We therefore created and studied a T cell line expressing the cloned δ-opioid receptor (DOR1). DOR1 ligation by a specific DOR1 agonist, deltorphin, augmented IL-2 secretion by synergizing with signals from TCR-CD3 and CD28. Reporter gene constructs were used to map this effect of deltorphin to the AP-1- and NF-AT/AP-1-binding sites of the IL-2 promoter. Although DOR1 signaling increased [Ca2+]i, deltorphin enhanced transcriptional activity of the NF-AT/AP-1-binding site via a mechanism independent of calcineurin and distinct from the effects of elevated [Ca2+]i. Deltorphin also increased accumulation of AP-1 transcription factor complexes, suggesting that DOR1 augments IL-2 secretion by increasing the AP-1 component of the NF-AT/AP-1 transcription factor. These results advance the molecular understanding of opioid effects on lymphocytes, and in addition, demonstrate regulation of IL-2 synthesis and secretion by the novel mechanism of receptor-mediated AP-1 induction.

Original languageEnglish (US)
Pages (from-to)5431-5440
Number of pages10
JournalJournal of Immunology
Volume159
Issue number11
StatePublished - Dec 1 1997

    Fingerprint

ASJC Scopus subject areas

  • Immunology

Cite this